Skip to main content

[Highly accessed] NAFLD as a continuum: from obesity to metabolic syndrome and diabetes

This review focuses on the clinical and pathophysiological connections between NAFLD, insulin resistance and type 2 diabetes. The authors reviewed non-invasive methods and several scoring systems for estimative of steatosis and fibrosis, proposing a multistep process for NAFLD evaluation. Treatment options are discussed, with a focus on the available therapies for obesity and/or type 2 diabetes that impact each stage of NAFLD.

Articles

About the editor

Dr. Sérgio VencioEditor-in-Chief Dr. Sérgio Vencio is active in the field of Endocrinology. He is a professor in the Post Graduate Program at the Federal University of Goiás, a Principal Investigator at the Pharmaceutical Institute of Science and has participated as a PI in more than 70 clinical studies. Since 2008, he has been the Editor of the Brazilian Diabetes Society Guidelines. He is the Coordinator of Neuroendocrinology at the Hospital Araujo Jorge, the Medical Director at Diagnostics of America - Atalaia, and a member of the Diabetes Board for the Brazilian Society of Endocrinology.

Covid-19 Collection

Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes

Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing

Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis

Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?

Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease

Announcement: Covid-19

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Our systems will continue to remind authors, reviewers and editors of the original timelines but we intend to be highly flexible at this time.

Aims and scope

Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.

By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.

The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.


The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics